FDA approves AstraZeneca, Nektar constipation drug

September 16, 2014 2:47 PM

7 0

FDA approves AstraZeneca, Nektar constipation drug

(Reuters) - The U.S. Food and Drug Administration approved an oral therapy to treat opioid-induced constipation developed by Nektar Therapeutics and AstraZeneca Plc.

The decision opens the door for peripherally acting mu opioid receptor antagonists, which have been linked with cardiovascular risk in the past.

Read more

To category page

Loading...